Administration of poly(I:C) Improved dermatophagoides farinae-induced atopic dermatitis-like skin lesions in NC/Nga mice by the regulation of Th1/Th2 balance

Vaccine

Volumn 30, Issue 14, 2012, Pages 2405-2410

  Kim, Chang Hyun ^a   Park, Chan Do ^b   Lee, Ai Young ^c  

^a Dongguk University   (South Korea)

^b Research Institute of Hurim Biocell   (South Korea)

^c Dongguk University College of Medicine   (South Korea)

Author keywords

Atopic dermatitis; NC Nga mice; Polyinosinic polycytidylic acid; Vaccine

Indexed keywords

EOTAXIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; POLYINOSINIC POLYCYTIDYLIC ACID; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ANIMAL CELL; ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DISEASE COURSE; EOSINOPHIL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 TH2 BALANCE; TH2 CELL;

ANIMALS; CYTOKINES; DERMATITIS, ATOPIC; DERMATOPHAGOIDES FARINAE; EOSINOPHILS; IMMUNOGLOBULIN E; IMMUNOLOGIC FACTORS; MALE; MAST CELLS; MICE; POLY I-C; SKIN; TH1 CELLS; TH1-TH2 BALANCE; TH2 CELLS;

EID: 84862810103     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.049     Document Type: Article

References (40)

1. Hoare C., Li Wan Po A., Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000, 4:1-191.
2. Leung D.Y., Bieber T. Atopic dermatitis. Lancet 2003, 361:151-160.
3. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004, 4:978-988.
4. Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., Hamid Q.A. New insights into atopic dermatitis. J Clin Invest 2004, 113:651-657.
5. Spergel J.M., Mizoguchi E., Oettgen H., Bhan A.K., Geha R.S. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999, 103:1103-1111.
6. Grewe M., Bruijnzeel-Koomen C.A., Schöpf E., Thepen T., Langeveld-Wildschut A.G., Ruzicka T., et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998, 19:359-361.
7. Brandt E.B., Sivaprasad U. Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2011, 10:2.
8. Miraglia del Giudice M., Decimo F., Leonardi S., Maioello N., Amelio R., Capasso A., et al. Immune dysregulation in atopic dermatitis. Allergy Asthma Proc 2006, 27:451-455.
9. Takakura M., Takeshita F., Aihara M., Xin K.Q., Ichino M., Okuda K., et al. Hyperproduction of IFN-gamma by CpG oligodeoxynucleotide-induced exacerbation of atopic dermatitis-like skin lesion in some NC/Nga mice. J Invest Dermatol 2005, 125:1156-1162.
10. Hattori K., Nishikawa M., Watcharanurak K., Ikoma A., Kabashima K., Toyota H., et al. Sustained exogenous expression of therapeutic levels of IFN-gamma ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization. J Immunol 2010, 184:2729-2735.
11. Sasakawa T., Higashi Y., Sakuma S., Hirayama Y., Sasakawa Y., Ohkubo Y., et al. Atopic dermatitis-like skin lesions induced by topical application of mite antigens in NC/Nga mice. Int Arch Allergy Immunol 2001, 126:239-247.
12. Jin H., He R., Oyoshi M., Geha R.S. Animal models of atopic dermatitis. J Invest Dermatol 2009, 129:31-40.
13. Vestergaard C., Yoneyama H., Murai M., Nakamura K., Tamaki K., Terashima Y., et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999, 104:1097-1105.
14. Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J., et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997, 9:461-466.
15. Kim C.H., Cheong K.A., Park C.D., Lee A.Y. Glucosamine improved atopic dermatitis-like skin lesions in NC/Nga mice by inhibition of Th2 cell development. Scand J Immunol 2011, 73:536-545.
16. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
17. Brown J.N., Kohler J.J., Coberley C.R., Sleasman J.W., Goodenow M.M. HIV-1 activates macrophages independent of Toll-like receptors. PLoS One 2008, 3:e3664.
18. Takeda K., Akira S. TLR signaling pathways. Semin Immunol 2004, 16:3-9.
19. Sutmuller R.P., Morgan M.E., Netea M.G., Grauer O., Adema G.J. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol 2006, 27:387-393.
20. Amos S.M., Pegram H.J., Westwood J.A., John L.B., Devaud C., Clarke C.J., et al. Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice. Cancer Immunol Immunother 2011, 60:671-683.
21. Ichinohe T., Watanabe I., Ito S., Fujii H., Moriyama M., Tamura S., et al. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J Virol 2005, 79:2910-2919.
22. Llopiz D., Dotor J., Zabaleta A., Lasarte J.J., Prieto J., Borrás-Cuesta F., et al. Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects. Cancer Immunol Immunother 2008, 57:19-29.
23. Cui Z., Qiu F. Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model. Cancer Immunol Immunother 2006, 55:1267-1279.
24. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., et al. Integral role of RF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005, 434:243-249.
25. Nordly P., Rose F., Christensen D., Nielsen H.M., Andersen P., Agger E.M., et al. Immunity y formulation design: induction of high CD8+ T-cell responses by poly(I:C) ncorporated into the CAF01 adjuvant via a double emulsion method. J Control Release 2011, 150:307-317.
26. Aumeunier A., Grela F., Ramadan A., Pham Van L., Bardel E., Gomez Alcala A., et al. ystemic Toll-like receptor stimulation suppresses experimental allergic asthma and utoimmune diabetes in NOD mice. PLoS One 2010, 5:e11484.
27. Sel S., Wegmann M., Sel S., Bauer S., Garn H., Alber G., et al. Immunomodulatory effectsof viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and L-10. J Immunol 2007, 178:7805-7813.
28. Yamamoto M., Haruna T., Yasui K., Takahashi H., Iduhara M., Takaki S., et al. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. Allergol Int 2007, 56:139-148.
29. Suto H., Matsuda H., Mitsuishi K., Hira K., Uchida T., Unno T., et al. NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 1999, 120:70-75.
30. Furue M. Atopic dermatitis-immunological abnormality and its background. J Dermatol Sci 1994, 7:159-168.
31. Inoue J., Aramaki Y. Suppression of skin lesions by transdermal application of CpG-oligodeoxynucleotides in NC/Nga mice, a model of human atopic dermatitis. J Immunol 2007, 178:584-591.
32. Farina G.A., York M.R., Di Marzio M., Collins C.A., Meller S., Homey B., et al. Poly(I:C)drives type I IFN- and TGFβ-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis. J Invest Dermatol 2010, 130:2583-2593.
33. Vercelli D., Geha R.S. Regulation of isotype switching. Curr Opin Immunol 1992, 4:794-797.
34. Fernandez-Botran R., Sanders V.M., Mosmann T.R., Vitetta E.S. Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J Exp Med 1988, 168:543-558.
35. Randolph D.A., Stephens R., Carruthers C.J., Chaplin D.D. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 1999, 104:10219.
36. Nakatani T., Kaburagi Y., Shimada Y., Inaoki M., Takehara K., Mukaida N., et al. CCR4 memory CD4+ T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis. J Allergy Clin Immunol 2001, 107:353-358.
37. Ma W., Bryce P.J., Humbles A.A., Laouini D., Yalcindag A., Alenius H., et al. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J Clin Invest 2002, 109:621-628.
38. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6(2):135-142.
39. Caron G., Delneste Y., Roelandts E., Duez C., Bonnefoy J.Y., Pestel J., et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001, 167(7):3682-3686.
40. Gosset P., Bureau F., Angeli V., Pichavant M., Faveeuw C., Tonnel A.B., et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J Immunol 2003, 170(10):4943-4952.